Humana Inc.HUM

Where HUM's Net Debt / EBITDA sits inside its own 10-year distribution, with the yearly high, low and average.

$401.54-4.98 (-1.23%)Previous close
NYSEHealthcare

HUM Net Debt / EBITDA: current value, 10-year range and year-by-year history

Net Debt / EBITDA History

Historically priceyAbove avgAround avgBelow avgHistorically cheap
HUM Net Debt / EBITDA historyHUM Net Debt / EBITDA from Sep 2023 to Jun 2026: low -0.66, high 3.17, latest 2.4.-0.960.151.262.373.48Sep 23Mar 24Sep 24Jun 25Dec 25Jun 26med 2.33

HUM Net Debt / EBITDA by year

Yearly range of HUM’s net debt / ebitda from 2016 to 2026. Over the full period it ranged from -1.5 to 3.2, averaging 0.8.

HUM Net Debt / EBITDA — yearly low, average, high and year-end values
YearLowAverageHighYear-end
20262.42.83.22.4
20252.32.53.03.0
20241.72.23.13.1
2023-0.8-0.11.61.6
2022-0.61.01.71.4
20210.61.42.22.2
2020-0.00.20.40.4
20190.20.50.80.5
2018-1.5-0.21.51.5
2017-1.5-0.70.20.2
2016-0.9-0.40.10.1

Get notified when HUM Net Debt / EBITDA crosses a threshold

Free — one alert setup, notifications by push, Telegram, or Discord.

How many years of operating earnings it would take to pay off the company's net debt. The most common leverage ratio — higher means more financial risk and less flexibility.

Formula(Total Debt − Cash) / EBITDA
Full guide
How to read this chart

Watch the trend more than the level. Declining ratio = deleveraging, growing financial flexibility. Rising ratio = increasing leverage, which constrains dividends, buybacks, and future investment.

Key caveats
  • Sector context is essential: 3× is aggressive for a consumer brand but normal for a regulated utility. Always compare to sector peers.
  • Large acquisitions spike the ratio temporarily — check whether the integration plan credibly drives paydown.
Pro — up to 30-year history

Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.